BHS DIAGNOSTICS LIMITED

Company number 12582387 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

BHS DIAGNOSTICS LIMITED - Analysis Report

Company Number: 12582387

Analysis Date: 2025-07-20 13:48 UTC

Financial Health Assessment of BHS DIAGNOSTICS LIMITED (as of 30 April 2024)


1. Financial Health Score: B+

Explanation:
BHS Diagnostics Limited demonstrates a solid financial footing with positive net current assets, growing shareholders’ funds, and consistent profitability. The business exhibits a "healthy cash flow" symptom with strong liquidity and low short-term liabilities. However, the company is very small scale (single director, single employee) and has modest capital base, limiting resilience to shocks. Overall, the score reflects a financially sound but still developing SME with room to strengthen working capital and diversify revenue streams.


2. Key Vital Signs:

Metric 2024 Value Interpretation
Current Assets £40,408 Adequate liquid assets available
Cash £40,408 Entirely cash-based current assets; excellent liquidity
Debtors £0 No outstanding receivables, reducing credit risk
Current Liabilities £4,315 Low short-term debts; manageable obligations
Net Current Assets £36,093 Strong working capital; "healthy cash flow"
Shareholders’ Funds £36,093 Solid equity base with gradual growth
Profit for the Year £5,792 The company is generating profits consistently
Dividends Paid £1,000 Moderate dividend payout, preserving capital
Employee Count 1 Very small operation; high dependency on director
Share Capital £10 Minimal capital invested; risks linked to scale

3. Diagnosis:

  • Liquidity & Working Capital: The company shows a strong liquidity position with all current assets held as cash and very low current liabilities. This indicates excellent capacity to meet short-term obligations without financial strain—a key sign of financial health. The absence of debtors suggests prompt collection or cash-based business, reducing risks of bad debts.

  • Profitability & Growth: Profit reserves have increased steadily from £14,797 in 2021 to £36,083 in 2024, reflecting consistent profitability and retained earnings. The director’s decision to retain the majority of profits within the business (only modest dividends paid) strengthens financial stability.

  • Capital Structure: The company’s share capital is nominal (£10), typical for small private limited companies. The shareholder equity growth is driven by retained profits rather than fresh capital injections. While this is positive, it also means the company’s financial "immune system" depends heavily on operational cash flows.

  • Size & Operational Risk: As a single-director, single-employee entity, the business is highly dependent on the director’s expertise and continuity. This creates a "single point of failure" risk. The company’s small scale limits diversification of revenue and operational flexibility.

  • Other Considerations: The company is active and compliant with filing duties, indicating good governance. The sector (specialists’ medical practice) is generally stable. No long-term liabilities or borrowings are recorded, keeping financial risk low.


4. Recommendations:

  • Build Debtor Base Carefully: While the current absence of debtors minimizes credit risk, cautious expansion of client credit terms could support growth. Establishing a controlled debtor ledger with clear credit policies would help manage cash flow and customer relationships.

  • Increase Capital Buffer: Consider increasing share capital or retaining more profits to build a stronger equity base. This will provide a larger financial cushion against unexpected downturns or investment needs.

  • Diversify Operational Capacity: Explore hiring or partnering to reduce dependency on the sole director and build operational resilience. This could include administrative support or additional medical specialists.

  • Monitor Cash Utilization: With all current assets in cash, ensure funds are optimally used—whether for growth investments, technology upgrades, or marketing—to avoid opportunity cost of idle cash.

  • Plan for Growth: Develop a strategic plan to grow client base and service offerings, balancing profitability with manageable risk. Track key performance indicators regularly to detect early signs of financial "symptoms" such as declining margins or rising liabilities.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.